Rajiv Mohanraj
Overview
Explore the profile of Rajiv Mohanraj including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
676
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Bezenac C, Leek N, Adan G, Mohanraj R, Biswas S, Marson A, et al.
Hum Brain Mapp
. 2024 Nov;
45(16):e70069.
PMID: 39508641
Patients with chronic focal epilepsy commonly exhibit subcortical atrophy, particularly of the thalamus. The timing of these alterations remains uncertain, though preliminary evidence suggests that observable changes may already be...
2.
Youshani A, Heal C, Lee J, Younis M, Mohanraj R, Maye H, et al.
Neurooncol Adv
. 2024 Sep;
6(1):vdae127.
PMID: 39220245
Background: Epileptic seizures commonly burden low-grade glioma (LGG) patients and negatively impact quality of life, neurocognition, and general patient health. Anti-seizure medications (ASMs) are used to manage seizures but can...
3.
Hutchcroft C, Whittam D, Azzopardi S, Todd R, Markey K, Dodd K, et al.
Pract Neurol
. 2024 Jul;
25(1):97.
PMID: 39059793
No abstract available.
4.
Allard J, Henley W, Sellers A, OShaughnessy E, Thomson O, McLean B, et al.
Epilepsy Behav
. 2024 Jun;
158:109906.
PMID: 38936308
Introduction: In England, nearly a quarter of people with intellectual disability (PwID) have epilepsy. Though 70 % of PwID have pharmaco-resistant seizures only 10 % are prescribed anti-seizure medication (ASMs)...
5.
Allard J, Sellers A, Henley W, McLean B, Parrett M, Rajakulendran S, et al.
Seizure
. 2024 Jun;
120:25-32.
PMID: 38897161
Introduction: People with Intellectual Disabilities (PwID) are twenty times more likely than general population to have epilepsy. Guidance for prescribing antiseizure medication (ASM) to PwID is driven by trials excluding...
6.
Delanty N, Mohanraj R, Shankar R, Wehner T, Stephen L, DSouza W, et al.
Epilepsy Res
. 2024 Mar;
202:107339.
PMID: 38492461
Genetic factors contribute to the aetiology of epilepsy in >50% of cases, and information on the use of antiseizure medications in people with specific aetiologies will help guide treatment decisions....
7.
DSouza W, Alsaadi T, Montoya J, Carreno M, Di Bonaventura C, Mohanraj R, et al.
Seizure
. 2022 Jul;
100:56-66.
PMID: 35777333
Purpose: To investigate the effectiveness, safety and tolerability of perampanel (PER) in treating myoclonic seizures in clinical practice, using data from the PERaMpanel pooled analysIs of effecTiveness and tolerability (PERMIT)...
8.
Marson A, Burnside G, Appleton R, Smith D, Leach J, Sills G, et al.
Health Technol Assess
. 2021 Dec;
25(75):1-134.
PMID: 34931602
Background: Levetiracetam (Keppra, UCB Pharma Ltd, Slough, UK) and zonisamide (Zonegran, Eisai Co. Ltd, Tokyo, Japan) are licensed as monotherapy for focal epilepsy, and levetiracetam is increasingly used as a...
9.
Pegg E, McKavanagh A, Bracewell R, Chen Y, Das K, Denby C, et al.
Brain Commun
. 2021 Sep;
3(3):fcab196.
PMID: 34514400
Despite an increasing number of drug treatment options for people with idiopathic generalized epilepsy (IGE), drug resistance remains a significant issue and the mechanisms underlying it remain poorly understood. Previous...
10.
Chen Y, Fallon N, Kreilkamp B, Denby C, Bracewell M, Das K, et al.
Hum Brain Mapp
. 2021 Aug;
42(17):5648-5664.
PMID: 34432348
It is well established that abnormal thalamocortical systems play an important role in the generation and maintenance of primary generalised seizures. However, it is currently unknown which thalamic nuclei and...